Bernstein Neutral On Medtronic With Slowing ICD Market (MDT, STJ, BSX)

Bernstein Research released their analysis of Medtronic Inc. (NYSE: MDT) and has a neutral stance for the stock with a price target of $40.

Full text available to premium subscribers only. Click here to subscribe to become a premium member. You have to be a registered user on the site to subscribe. If you are not a registered user click here to register at the site.

There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.

Post new comment

The content of this field is kept private and will not be shown publicly.